Eleuterio Ferrannini - Publications, H-index & Citations

Eleuterio Ferrannini

consiglio nazionale delle ricerche (cnr)

71H指数

278论文数

2.7W被引数

收录论文 42

发表时间

CAPIRE score predicts long-term major cardiac events CAPIRE评分预测长期主要心血管事件

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

IF1.5

2026-01-01

PREAI

Andreini, Daniele; Conte, Edoardo; Magnoni, Marco; Mushtaq, Saima; Bonomi, Alice; Latini, Roberto; Gorini, Marco; Andreotti, Felicita; Ferrannini, Eleuterio; Mercuro, Giuseppe; Bartorelli, Antonio L.; Montecucco, Fabrizio; Maggioni, Aldo P.

Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 x 2 phenotypic CAPIRE study 代谢组学与冠状动脉粥样硬化、心血管风险、两者或两者都不相关。2x2表型CAPIRE研究的结果

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2021-08-01

PREAI

Deidda, Martino; Noto, Antonio; Dessalvi, Christian Cadeddu; Andreini, Daniele; Andreotti, Felicita; Ferrannini, Eleuterio; Latini, Roberto; Maggioni, Aldo P.; Magnoni, Marco; Maseri, Attilio; Mercuro, Giuseppe

microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function

MOLECULAR METABOLISM

IF6.6

2018-11-01

OAAI

Langlet, Fanny; Tarbier, Marcel; Haeusler, Rebecca A.; Camastra, Stefania; Ferrannini, Eleuterio; Friedlander, Marc R.; Accili, Domenico

Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

IF3.5

2014-03-22

PREAI

Santini, E.; Madec, S.; Corretti, V.; Ferrannini, E.; Solini, A.

Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (vol 35, pg 1364, 2012)

DIABETES CARE

IF16.6

2013-01-17

OAAI

Inzucchi, S. E.; Bergenstal, R. M.; Buse, J. B.; Diamant, M.; Ferrannini, E.; Nauck, M.; Peters, A. L.; Tsapas, A.; Wender, R.; Matthews, D. R.

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (vol 55, pg 1577, 2012)

DIABETOLOGIA

IF10.2

2012-12-16

OAAI

Inzucchi, S. E.; Bergenstal, R. M.; Buse, J. B.; Diamant, M.; Ferrannini, E.; Nauck, M.; Peters, A. L.; Tsapas, A.; Wender, R.; Matthews, D. R.

HIGH SERUM LEVELS OF CXC (CXCL10) AND CC (CCL2) CHEMOKINES IN UNTREATED ESSENTIAL HYPERTENSION

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

IF2.6

2012-04-01

PREAI

Antonelli, A.; Fallahi, P.; Ferrari, S. M.; Ghiadoni, L.; Virdis, A.; Mancusi, C.; Centanni, M.; Taddei, S.; Ferrannini, E.

Endothelial dysfunction in type 2 diabetes

DIABETOLOGIA

IF10.2

2012-01-20

OAAI

Natali, A.; Ferrannini, E.

Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans PNPLA3 (adiponutrin) 的遗传变异赋予对减肥引起的人类肝脏脂肪减少的敏感性

AMERICAN JOURNAL OF CLINICAL NUTRITION

IF6.9

2011-07-01

132

PREAI

Sevastianova, Ksenia; Kotronen, Anna; Gastaldelli, Amalia; Perttila, Julia; Hakkarainen, Antti; Lundbom, Jesper; Suojanen, Laura; Orho-Melander, Marju; Lundbom, Nina; Ferrannini, Eleuterio; Rissanen, Aila; Olkkonen, Vesa M.; Yki-Jarvinen, Hannele

High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive

DIABETES OBESITY & METABOLISM

IF5.7

2011-06-21

PREAI

Ferrannini, E.; Betteridge, D. J.; Dormandy, J. A.; Charbonnel, B.; Wilcox, R. G.; Spanheimer, R.; Erdmann, E.; DeFronzo, R. A.; Laakso, M.

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

DIABETES OBESITY & METABOLISM

IF5.7

2010-07-23

179

PREAI

Matthews, D. R.; Dejager, S.; Ahren, B.; Fonseca, V.; Ferrannini, E.; Couturier, A.; Foley, J. E.; Zinman, B.

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

DIABETES OBESITY & METABOLISM

IF5.7

2008-12-29

252

PREAI

Ferrannini, E.; Fonseca, V.; Zinman, B.; Matthews, D.; Ahren, B.; Byiers, S.; Shao, Q.; Dejager, S.

Effects of different LDL particles on inflammatory molecules in human mesangial cells

DIABETOLOGIA

IF10.2

2008-08-28

OAAI

Santini, E.; Lupi, R.; Baldi, S.; Madec, S.; Chimenti, D.; Ferrannini, E.; Solini, A.

Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes

DIABETIC MEDICINE

IF3.4

2008-06-28

OAAI

Mari, A.; Tura, A.; Pacini, G.; Kautzky-Willer, A.; Ferrannini, E.

Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients

DIABETOLOGIA

IF10.2

2007-12-14

OAAI

Jazet, I. M.; Schaart, G.; Gastaldelli, A.; Ferrannini, E.; Hesselink, M. K.; Schrauwen, P.; Romijn, J. A.; Maassen, J. A.; Pijl, H.; Ouwens, D. M.; Meinders, A. E.

The effect of pioglitazone on the liver - Role of adiponectin

DIABETES CARE

IF16.6

2006-10-01

OAAI

Gastaldelli, Amalia; Miyazaki, Yoshinori; Mahankali, Archana; Berria, Rachele; Pettiti, Maura; Buzzigoli, Emma; Ferrannini, Eleuterio; DeFronzo, Ralph A.

High glucose and homocysteine synergistically affect the metalloproteinases-tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts

DIABETOLOGIA

IF10.2

2006-08-01

OAAI

Solini, A.; Santini, E.; Nannipieri, M.; Ferrannini, E.

Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects (vol 49, pg 1131, 2006)

DIABETOLOGIA

IF10.2

2006-04-07

OAAI

Walker, M; Mari, A; Jayapaul, MK; Bennett, SMA; Ferrannini, E